// =============================================================================
// Aurivian x Nestle Health Science — Claim Substantiation Demo Data
// =============================================================================
// Mock datasets for three ingredient-claim pairs used to demonstrate
// Aurivian's AI-powered evidence ingestion, analysis, and claim generation.
// =============================================================================

// ---------------------------------------------------------------------------
// Ingredient selector options
// ---------------------------------------------------------------------------
export const INGREDIENT_OPTIONS = [
  {
    id: 'magnesium_sleep',
    ingredient: 'Magnesium',
    claim: 'Sleep Quality Support',
    label: 'Magnesium + Sleep',
  },
  {
    id: 'red_clover_menopause',
    ingredient: 'Red Clover (Trifolium pratense)',
    claim: 'Menopause Symptom Relief',
    label: 'Red Clover + Menopause',
  },
  {
    id: 'collagen_skin',
    ingredient: 'Collagen Peptides',
    claim: 'Skin Elasticity Improvement',
    label: 'Collagen + Skin Elasticity',
  },
];

// ===========================================================================
// 1. MAGNESIUM + SLEEP
// ===========================================================================
const magnesiumSleep = {
  ingredientId: 'magnesium_sleep',
  ingredient: 'Magnesium',
  claimArea: 'Sleep Quality Support',

  // ---- Ingestion stats ---------------------------------------------------
  ingestion: {
    totalPapersIdentified: 458,
    fullTextAccessed: 382,
    duplicatesRemoved: 34,
    excludedAfterScreening: 42,
    dataSources: [
      { name: 'PubMed / MEDLINE', papers: 196 },
      { name: 'ClinicalTrials.gov', papers: 47 },
      { name: 'Cochrane Library', papers: 28 },
      { name: 'Internal Nestlé R&D Archive', papers: 35 },
      { name: 'J-STAGE', papers: 31 },
      { name: 'CiNii', papers: 18 },
      { name: 'Consumer / Social Media', papers: 103 },
    ],
    languagesDetected: ['English', 'Japanese', 'German', 'Spanish', 'Korean', 'Chinese'],
    dateRange: { from: '1992-01-01', to: '2026-01-01' },
    avgProcessingTimeSec: 0.42,
  },

  // ---- Studies -----------------------------------------------------------
  studies: [
    {
      id: 'MG-001',
      title: 'Effect of magnesium glycinate supplementation on subjective sleep quality in adults with mild insomnia: a randomized, double-blind, placebo-controlled trial',
      authors: ['Abbasi B', 'Kimiagar M', 'Sadeghi K', 'Shirazi MM'],
      year: 2022,
      journal: 'Journal of Research in Medical Sciences',
      language: 'English',
      qualityScore: 91,
      studyDesign: 'RCT',
      population: 'Adults 30-65 with PSQI > 5',
      sampleSize: 126,
      dose: '400 mg elemental Mg (as glycinate)',
      form: 'Magnesium glycinate',
      duration: '8 weeks',
      endpoints: ['PSQI global score', 'sleep onset latency', 'sleep efficiency'],
      outcome: 'supporting',
      effectSummary: 'PSQI improved by 3.4 points vs 0.8 in placebo (p<0.001). SOL reduced by 12.3 min.',
    },
    {
      id: 'MG-002',
      title: 'Oral magnesium supplementation and sleep quality: a systematic review and meta-analysis of randomized controlled trials',
      authors: ['Mah J', 'Pitre T'],
      year: 2021,
      journal: 'BMC Complementary Medicine and Therapies',
      language: 'English',
      qualityScore: 88,
      studyDesign: 'systematic-review',
      population: 'Adults with sleep complaints',
      sampleSize: 1215,
      dose: '225-500 mg/day elemental Mg',
      form: 'Multiple forms',
      duration: 'Varied (4-12 weeks)',
      endpoints: ['PSQI global score', 'total sleep time'],
      outcome: 'supporting',
      effectSummary: 'Pooled analysis showed significant improvement in PSQI (SMD -0.82, 95% CI -1.18 to -0.46).',
    },
    {
      id: 'MG-003',
      title: 'Magnesium L-threonate enhances sleep-related brain wave patterns: a double-blind crossover polysomnography study',
      authors: ['Slutsky I', 'Abumaria N', 'Wu LJ', 'Bhatt DK'],
      year: 2023,
      journal: 'Sleep Medicine',
      language: 'English',
      qualityScore: 87,
      studyDesign: 'RCT',
      population: 'Adults 40-70 with subjective sleep complaints',
      sampleSize: 88,
      dose: '2000 mg Mg L-threonate (144 mg elemental Mg)',
      form: 'Magnesium L-threonate',
      duration: '6 weeks',
      endpoints: ['sleep efficiency', 'PSQI global score', 'slow-wave sleep duration'],
      outcome: 'supporting',
      effectSummary: 'Sleep efficiency increased by 4.2% (p=0.009). Slow-wave sleep duration increased 18 min vs placebo.',
    },
    {
      id: 'MG-004',
      title: 'Comparison of magnesium citrate and magnesium oxide on sleep quality and serum magnesium in older adults: a parallel-group RCT',
      authors: ['Nielsen FH', 'Johnson LK', 'Zeng H'],
      year: 2020,
      journal: 'Magnesium Research',
      language: 'English',
      qualityScore: 82,
      studyDesign: 'RCT',
      population: 'Adults 60-75 with low serum Mg',
      sampleSize: 94,
      dose: '320 mg/day elemental Mg',
      form: 'Magnesium citrate vs oxide',
      duration: '12 weeks',
      endpoints: ['PSQI global score', 'sleep onset latency', 'serum Mg levels'],
      outcome: 'supporting',
      effectSummary: 'Both forms improved PSQI; citrate showed greater SOL reduction (-14.7 min vs -8.2 min, p=0.03).',
    },
    {
      id: 'MG-005',
      title: 'The effect of magnesium taurate on nocturnal leg cramps and sleep disturbance: a pilot RCT',
      authors: ['Eby GA', 'Eby KL'],
      year: 2019,
      journal: 'Journal of the American College of Nutrition',
      language: 'English',
      qualityScore: 74,
      studyDesign: 'RCT',
      population: 'Adults 45-70 with nocturnal cramps',
      sampleSize: 52,
      dose: '375 mg elemental Mg (as taurate)',
      form: 'Magnesium taurate',
      duration: '6 weeks',
      endpoints: ['nocturnal cramp frequency', 'PSQI global score', 'total sleep time'],
      outcome: 'supporting',
      effectSummary: 'Cramp frequency reduced 62%. PSQI improved 2.1 points (p=0.014).',
    },
    {
      id: 'MG-006',
      title: 'Magnesium oxide supplementation and sleep in community-dwelling elderly: no significant effect in a randomized trial',
      authors: ['Veronese N', 'Demurtas J', 'Pesolillo G'],
      year: 2021,
      journal: 'Nutrients',
      language: 'English',
      qualityScore: 79,
      studyDesign: 'RCT',
      population: 'Community-dwelling elderly 70+',
      sampleSize: 108,
      dose: '500 mg MgO (300 mg elemental Mg)',
      form: 'Magnesium oxide',
      duration: '8 weeks',
      endpoints: ['PSQI global score', 'sleep onset latency'],
      outcome: 'neutral',
      effectSummary: 'No significant difference in PSQI (p=0.21). Marginal SOL reduction of 4.1 min (p=0.08).',
    },
    {
      id: 'MG-007',
      title: 'マグネシウム補充と睡眠の質に関する日本人成人を対象とした二重盲検試験',
      authors: ['Tanaka H', 'Shirakawa S', 'Funahashi M'],
      year: 2020,
      journal: 'J-STAGE: 日本栄養・食糧学会誌',
      language: 'Japanese',
      qualityScore: 83,
      studyDesign: 'RCT',
      population: 'Japanese adults 30-55',
      sampleSize: 72,
      dose: '300 mg elemental Mg (as glycinate)',
      form: 'Magnesium glycinate',
      duration: '8 weeks',
      endpoints: ['PSQI global score', 'Oguri-Shirakawa-Azumi sleep inventory'],
      outcome: 'supporting',
      effectSummary: 'Significant improvement in both OSA-MA sleep score (p=0.003) and PSQI (p=0.008).',
    },
    {
      id: 'MG-008',
      title: 'マグネシウムと睡眠潜時に関する用量反応関係の検討',
      authors: ['Yamamoto K', 'Uchida S', 'Noda A'],
      year: 2018,
      journal: 'J-STAGE: 睡眠医療',
      language: 'Japanese',
      qualityScore: 76,
      studyDesign: 'cohort',
      population: 'Japanese shift workers',
      sampleSize: 148,
      dose: '200-500 mg/day elemental Mg',
      form: 'Magnesium citrate',
      duration: '12 weeks',
      endpoints: ['sleep onset latency', 'actigraphy-measured sleep'],
      outcome: 'supporting',
      effectSummary: 'Dose-dependent reduction in SOL. Threshold effect observed at 300 mg/day.',
    },
    {
      id: 'MG-009',
      title: '高齢者における酸化マグネシウム摂取と睡眠の質の関連',
      authors: ['Okawa M', 'Mishima K', 'Hishikawa Y'],
      year: 2017,
      journal: 'CiNii: 老年医学',
      language: 'Japanese',
      qualityScore: 68,
      studyDesign: 'cohort',
      population: 'Japanese elderly (70+)',
      sampleSize: 210,
      dose: '250 mg elemental Mg (as oxide)',
      form: 'Magnesium oxide',
      duration: '16 weeks',
      endpoints: ['PSQI global score', 'daytime sleepiness'],
      outcome: 'neutral',
      effectSummary: 'Modest non-significant trend toward PSQI improvement (p=0.11). Compliance issues noted.',
    },
    {
      id: 'MG-010',
      title: 'Association between dietary magnesium intake and sleep duration: NHANES 2005-2016 analysis',
      authors: ['Cao Y', 'Zhen S', 'Taylor AW', 'Appleton S'],
      year: 2018,
      journal: 'Nutrients',
      language: 'English',
      qualityScore: 72,
      studyDesign: 'cohort',
      population: 'US adults 20+',
      sampleSize: 26211,
      dose: 'Dietary intake (quartiles)',
      form: 'Dietary magnesium',
      duration: 'Cross-sectional',
      endpoints: ['total sleep time', 'short sleep prevalence'],
      outcome: 'supporting',
      effectSummary: 'Highest Mg quartile associated with 17% lower odds of short sleep (OR 0.83, 95% CI 0.74-0.93).',
    },
    {
      id: 'MG-011',
      title: 'The effects of magnesium supplementation on sleep: a meta-analysis of randomized controlled trials',
      authors: ['Arab A', 'Rafie N', 'Amani R', 'Shirani F'],
      year: 2023,
      journal: 'Biological Trace Element Research',
      language: 'English',
      qualityScore: 85,
      studyDesign: 'meta-analysis',
      population: 'Adults with and without insomnia',
      sampleSize: 2034,
      dose: '200-500 mg/day',
      form: 'Multiple forms',
      duration: 'Varied',
      endpoints: ['PSQI global score', 'sleep onset latency', 'total sleep time'],
      outcome: 'supporting',
      effectSummary: 'Significant reduction in PSQI (WMD -1.85, p<0.001). Larger effects in those with insomnia.',
    },
    {
      id: 'MG-012',
      title: 'Magnesium glycinate does not improve sleep in healthy young adults without deficiency: a randomized trial',
      authors: ['Rondanelli M', 'Faliva MA', 'Tartara A'],
      year: 2022,
      journal: 'European Journal of Clinical Nutrition',
      language: 'English',
      qualityScore: 81,
      studyDesign: 'RCT',
      population: 'Healthy adults 18-35 with normal Mg',
      sampleSize: 64,
      dose: '400 mg elemental Mg (as glycinate)',
      form: 'Magnesium glycinate',
      duration: '8 weeks',
      endpoints: ['PSQI global score', 'sleep onset latency', 'sleep efficiency'],
      outcome: 'negative',
      effectSummary: 'No significant changes in any sleep parameter. Suggests benefit may require baseline deficiency.',
    },
    {
      id: 'MG-013',
      title: 'Magnesium and the regulation of circadian rhythm: implications for sleep disorders',
      authors: ['Durlach J', 'Pages N', 'Bac P', 'Bara M'],
      year: 2002,
      journal: 'Magnesium Research',
      language: 'English',
      qualityScore: 65,
      studyDesign: 'case-report',
      population: 'Case series, adults with Mg deficiency',
      sampleSize: 12,
      dose: '300-600 mg elemental Mg (various)',
      form: 'Multiple forms',
      duration: '4-10 weeks',
      endpoints: ['circadian rhythm markers', 'sleep quality subjective'],
      outcome: 'supporting',
      effectSummary: 'Correction of Mg deficiency associated with normalization of melatonin secretion patterns.',
    },
    {
      id: 'MG-014',
      title: 'Comparative bioavailability of magnesium salts and their effects on sleep EEG parameters',
      authors: ['Hartle JW', 'Morgan S', 'Poulsen T'],
      year: 2024,
      journal: 'Journal of Nutritional Science',
      language: 'English',
      qualityScore: 84,
      studyDesign: 'RCT',
      population: 'Adults 35-60 with poor sleep',
      sampleSize: 180,
      dose: '300 mg elemental Mg (glycinate vs citrate vs oxide)',
      form: 'Three-arm comparison',
      duration: '10 weeks',
      endpoints: ['sleep onset latency', 'sleep efficiency', 'serum Mg'],
      outcome: 'supporting',
      effectSummary: 'Glycinate and citrate superior to oxide for SOL reduction. Glycinate showed best sleep efficiency gain.',
    },
    {
      id: 'MG-015',
      title: 'Low-dose magnesium citrate for sleep quality in perimenopausal women: a pilot study',
      authors: ['Held K', 'Antonijevic IA', 'Kunzel H', 'Steiger A'],
      year: 2021,
      journal: 'Menopause',
      language: 'English',
      qualityScore: 70,
      studyDesign: 'RCT',
      population: 'Perimenopausal women 45-55',
      sampleSize: 38,
      dose: '200 mg elemental Mg (as citrate)',
      form: 'Magnesium citrate',
      duration: '8 weeks',
      endpoints: ['PSQI global score', 'hot flash-related awakenings'],
      outcome: 'supporting',
      effectSummary: 'PSQI improved 2.6 points (p=0.02). Night-time awakenings from hot flashes reduced 34%.',
    },
    {
      id: 'MG-016',
      title: 'Magnesium supplementation and insomnia severity index: a Bayesian adaptive trial',
      authors: ['Zhang Y', 'Chen C', 'Lu J', 'Li L'],
      year: 2024,
      journal: 'Sleep Medicine Reviews',
      language: 'English',
      qualityScore: 90,
      studyDesign: 'RCT',
      population: 'Adults 25-60 with ISI >= 10',
      sampleSize: 210,
      dose: '350 mg elemental Mg (as glycinate)',
      form: 'Magnesium glycinate',
      duration: '12 weeks',
      endpoints: ['ISI score', 'PSQI global score', 'actigraphy measures'],
      outcome: 'supporting',
      effectSummary: 'ISI decreased by 5.7 points (clinically meaningful). Posterior probability of superiority 98.2%.',
    },
    {
      id: 'MG-017',
      title: 'Sleep-promoting effects of magnesium L-threonate versus glycinate in stressed adults: head-to-head comparison',
      authors: ['Pickering G', 'Mazur A', 'Trousselard M'],
      year: 2025,
      journal: 'Frontiers in Nutrition',
      language: 'English',
      qualityScore: 86,
      studyDesign: 'RCT',
      population: 'Adults 30-55 with perceived stress and poor sleep',
      sampleSize: 156,
      dose: 'L-threonate 2000mg vs glycinate 400mg elemental Mg',
      form: 'Magnesium L-threonate vs glycinate',
      duration: '8 weeks',
      endpoints: ['PSQI global score', 'sleep onset latency', 'perceived stress scale'],
      outcome: 'supporting',
      effectSummary: 'Both forms improved PSQI. L-threonate showed numerically greater SOL reduction but not statistically different (p=0.07).',
    },
  ],

  // ---- Ingredient forms --------------------------------------------------
  ingredientForms: [
    {
      form: 'Magnesium glycinate (bisglycinate)',
      elementalMgPercent: 14.1,
      bioavailability: 'High',
      efficacySummary: 'Strongest evidence for sleep quality. Well-tolerated, low GI side effects. Glycine itself may contribute to sleep benefit.',
      studyCount: 8,
    },
    {
      form: 'Magnesium citrate',
      elementalMgPercent: 16.2,
      bioavailability: 'High',
      efficacySummary: 'Good evidence for SOL reduction. Higher bioavailability than oxide. May cause loose stools at higher doses.',
      studyCount: 5,
    },
    {
      form: 'Magnesium oxide',
      elementalMgPercent: 60.3,
      bioavailability: 'Low',
      efficacySummary: 'High elemental Mg per dose but poor absorption. Mixed results for sleep; most neutral outcomes. Primarily used for Mg repletion.',
      studyCount: 4,
    },
    {
      form: 'Magnesium L-threonate',
      elementalMgPercent: 7.2,
      bioavailability: 'High (CNS-targeted)',
      efficacySummary: 'Unique ability to cross blood-brain barrier. Promising for sleep architecture improvements (slow-wave sleep). Limited but growing trial base.',
      studyCount: 3,
    },
    {
      form: 'Magnesium taurate',
      elementalMgPercent: 8.9,
      bioavailability: 'Moderate-High',
      efficacySummary: 'Taurine co-factor may enhance GABAergic activity. Limited dedicated sleep RCTs. Promising in populations with nocturnal cramps.',
      studyCount: 2,
    },
  ],

  // ---- Endpoint analysis -------------------------------------------------
  endpointAnalysis: [
    {
      endpoint: 'PSQI Global Score',
      totalStudies: 14,
      supporting: 10,
      neutral: 3,
      negative: 1,
      averageEffectSize: 'SMD -0.82 (moderate-large)',
    },
    {
      endpoint: 'Sleep Onset Latency (SOL)',
      totalStudies: 11,
      supporting: 8,
      neutral: 2,
      negative: 1,
      averageEffectSize: 'WMD -11.2 min',
    },
    {
      endpoint: 'Total Sleep Time',
      totalStudies: 8,
      supporting: 5,
      neutral: 3,
      negative: 0,
      averageEffectSize: 'WMD +17.4 min',
    },
    {
      endpoint: 'Sleep Efficiency',
      totalStudies: 7,
      supporting: 5,
      neutral: 2,
      negative: 0,
      averageEffectSize: 'Mean +3.8%',
    },
  ],

  // ---- Dosage ranges -----------------------------------------------------
  dosageRanges: [
    { form: 'Magnesium glycinate', effectiveDose: '300-400 mg elemental Mg/day', optimalDose: '350 mg/day', timing: 'Evening, 30-60 min before bed' },
    { form: 'Magnesium citrate', effectiveDose: '200-400 mg elemental Mg/day', optimalDose: '300 mg/day', timing: 'Evening, with food' },
    { form: 'Magnesium oxide', effectiveDose: '300-500 mg elemental Mg/day', optimalDose: '400 mg/day', timing: 'Evening (note low bioavailability)' },
    { form: 'Magnesium L-threonate', effectiveDose: '1500-2000 mg Mg-L-threonate/day (108-144 mg elemental Mg)', optimalDose: '2000 mg/day', timing: 'Divided AM/PM or evening' },
    { form: 'Magnesium taurate', effectiveDose: '300-400 mg elemental Mg/day', optimalDose: '375 mg/day', timing: 'Evening' },
  ],

  // ---- Research gaps -----------------------------------------------------
  researchGaps: [
    { gap: 'Limited pediatric sleep data', severity: 'High', detail: 'Only 2 studies in adolescents; no data in children under 12.' },
    { gap: 'Few head-to-head form comparisons', severity: 'High', detail: 'Only 2 RCTs directly compare bioavailable forms for sleep outcomes.' },
    { gap: 'Dose-response relationship unclear', severity: 'Moderate', detail: 'Most RCTs test single dose; limited titration or dose-ranging studies.' },
    { gap: 'Long-term maintenance data', severity: 'Moderate', detail: 'Longest RCT is 16 weeks. No data on sustained benefit beyond 6 months.' },
    { gap: 'Interaction with sleep medications', severity: 'Moderate', detail: 'Minimal data on co-administration with melatonin, zolpidem, or other sleep aids.' },
    { gap: 'Objective PSG data limited', severity: 'Low', detail: 'Most studies use PSQI (subjective). Only 3 studies include polysomnography.' },
  ],

  // ---- Suggested claims --------------------------------------------------
  suggestedClaims: [
    {
      claimText: 'Magnesium glycinate supplementation (300-400 mg/day elemental Mg) supports improvement in overall sleep quality as measured by validated instruments in adults with suboptimal magnesium status.',
      confidence: 'Strong',
      evidenceLevel: '1a (multiple RCTs + meta-analysis)',
      regulatoryContext: 'Suitable for structure/function claim (21 CFR 101.93). Consistent with EFSA Art. 13.1 positive Mg opinion.',
      supportingStudyCount: 12,
    },
    {
      claimText: 'Magnesium supplementation may help reduce the time it takes to fall asleep in individuals experiencing occasional sleeplessness.',
      confidence: 'Moderate',
      evidenceLevel: '1b (multiple RCTs, moderate heterogeneity)',
      regulatoryContext: 'Structure/function claim with qualifier "may help." Avoid disease claims (insomnia).',
      supportingStudyCount: 8,
    },
    {
      claimText: 'Magnesium L-threonate, a brain-bioavailable form, shows emerging evidence for supporting healthy sleep architecture and deep sleep.',
      confidence: 'Emerging',
      evidenceLevel: '2b (limited RCTs, mechanistic support)',
      regulatoryContext: 'Requires qualifying language. Not yet suitable for standalone health claim in EU. Acceptable as S/F in US with disclaimers.',
      supportingStudyCount: 3,
    },
  ],

  // ---- Consumer / social data -------------------------------------------
  consumerSocial: {
    sentimentScore: 0.74,
    sampleSize: 14820,
    dataWindow: '2024-01-01 to 2025-10-31',
    commonQuestions: [
      'Which form of magnesium is best for sleep?',
      'How much magnesium should I take before bed?',
      'Does magnesium glycinate make you drowsy?',
      'Can I take magnesium with melatonin?',
      'How long does it take for magnesium to help sleep?',
    ],
    brandMentions: [
      { brand: 'Pure Encapsulations', mentions: 3240, sentiment: 0.81, topAssociation: 'magnesium glycinate quality' },
      { brand: 'Solgar', mentions: 2180, sentiment: 0.72, topAssociation: 'magnesium citrate value' },
      { brand: "Nature's Bounty", mentions: 1560, sentiment: 0.64, topAssociation: 'magnesium oxide accessibility' },
      { brand: 'Vital Proteins', mentions: 420, sentiment: 0.68, topAssociation: 'magnesium in wellness stacks' },
    ],
    topChannels: [
      { channel: 'Reddit (r/Supplements, r/sleep)', posts: 4870 },
      { channel: 'TikTok', posts: 3620 },
      { channel: 'Amazon Reviews', posts: 3150 },
      { channel: 'Instagram', posts: 1890 },
      { channel: 'YouTube', posts: 1290 },
    ],
  },
};

// ===========================================================================
// 2. RED CLOVER + MENOPAUSE
// ===========================================================================
const redCloverMenopause = {
  ingredientId: 'red_clover_menopause',
  ingredient: 'Red Clover (Trifolium pratense)',
  claimArea: 'Menopause Symptom Relief',

  // ---- Ingestion stats ---------------------------------------------------
  ingestion: {
    totalPapersIdentified: 324,
    fullTextAccessed: 271,
    duplicatesRemoved: 22,
    excludedAfterScreening: 31,
    dataSources: [
      { name: 'PubMed / MEDLINE', papers: 142 },
      { name: 'ClinicalTrials.gov', papers: 31 },
      { name: 'Cochrane Library', papers: 19 },
      { name: 'Internal Nestlé R&D Archive', papers: 24 },
      { name: 'EMBASE', papers: 38 },
      { name: 'Consumer / Social Media', papers: 70 },
    ],
    languagesDetected: ['English', 'German', 'Italian', 'Spanish', 'Portuguese'],
    dateRange: { from: '1998-01-01', to: '2025-12-01' },
    avgProcessingTimeSec: 0.38,
  },

  // ---- Studies -----------------------------------------------------------
  studies: [
    {
      id: 'RC-001',
      title: 'Efficacy of a standardized red clover extract (Promensil) on hot flash frequency and severity in postmenopausal women: a randomized, double-blind, placebo-controlled trial',
      authors: ['Tice JA', 'Ettinger B', 'Ensrud K', 'Wallace R'],
      year: 2003,
      journal: 'JAMA',
      language: 'English',
      qualityScore: 93,
      studyDesign: 'RCT',
      population: 'Postmenopausal women 45-60',
      sampleSize: 252,
      dose: '82 mg total isoflavones (Promensil)',
      form: 'Promensil extract',
      duration: '12 weeks',
      endpoints: ['hot flash frequency', 'hot flash severity'],
      outcome: 'supporting',
      effectSummary: 'Hot flash frequency reduced 44% vs 22% placebo (p=0.01). Severity score improved significantly.',
    },
    {
      id: 'RC-002',
      title: 'Red clover isoflavones for the reduction of menopausal symptoms: a systematic review and meta-analysis',
      authors: ['Lethaby A', 'Marjoribanks J', 'Kronenberg F', 'Roberts H'],
      year: 2013,
      journal: 'Cochrane Database of Systematic Reviews',
      language: 'English',
      qualityScore: 95,
      studyDesign: 'meta-analysis',
      population: 'Peri- and postmenopausal women',
      sampleSize: 1876,
      dose: '40-160 mg isoflavones/day',
      form: 'Multiple red clover extracts',
      duration: '3-12 months',
      endpoints: ['hot flash frequency', 'Kupperman index', 'quality of life'],
      outcome: 'supporting',
      effectSummary: 'Significant reduction in hot flash frequency (WMD -1.31 flashes/day, 95% CI -2.02 to -0.61).',
    },
    {
      id: 'RC-003',
      title: 'The effect of MF11RCE standardized red clover extract on the Kupperman menopausal index: a 16-week randomized controlled trial',
      authors: ['Lipovac M', 'Chedraui P', 'Gruenhut C', 'Gocan A'],
      year: 2015,
      journal: 'Maturitas',
      language: 'English',
      qualityScore: 86,
      studyDesign: 'RCT',
      population: 'Postmenopausal women with Kupperman index >= 20',
      sampleSize: 109,
      dose: '80 mg total isoflavones (MF11RCE)',
      form: 'MF11RCE',
      duration: '16 weeks',
      endpoints: ['Kupperman index', 'hot flash frequency', 'mood symptoms'],
      outcome: 'supporting',
      effectSummary: 'Kupperman index decreased 14.8 points vs 5.3 in placebo (p<0.001).',
    },
    {
      id: 'RC-004',
      title: 'Red clover isoflavones and bone mineral density in postmenopausal women: a double-blind, placebo-controlled study',
      authors: ['Atkinson C', 'Compston JE', 'Day NE', 'Dowsett M'],
      year: 2004,
      journal: 'American Journal of Clinical Nutrition',
      language: 'English',
      qualityScore: 88,
      studyDesign: 'RCT',
      population: 'Postmenopausal women 49-65',
      sampleSize: 177,
      dose: '40 mg isoflavones/day (Promensil)',
      form: 'Promensil extract',
      duration: '12 months',
      endpoints: ['lumbar spine BMD', 'femoral neck BMD', 'bone turnover markers'],
      outcome: 'supporting',
      effectSummary: 'Lumbar spine BMD loss attenuated (-0.4% vs -1.9% placebo, p=0.04). NTx markers reduced.',
    },
    {
      id: 'RC-005',
      title: 'Effect of red clover-derived isoflavones on serum lipid profile in postmenopausal women: a randomized controlled trial',
      authors: ['Nestel PJ', 'Pomeroy S', 'Kay S', 'Komesaroff P'],
      year: 2004,
      journal: 'Clinical Endocrinology',
      language: 'English',
      qualityScore: 84,
      studyDesign: 'RCT',
      population: 'Postmenopausal women with mild hyperlipidemia',
      sampleSize: 80,
      dose: '80 mg isoflavones/day',
      form: 'Promensil extract',
      duration: '8 weeks',
      endpoints: ['total cholesterol', 'LDL-C', 'HDL-C', 'triglycerides'],
      outcome: 'supporting',
      effectSummary: 'HDL-C increased 15.7% (p=0.01). LDL-C decreased 9.5% (p=0.04). TG unchanged.',
    },
    {
      id: 'RC-006',
      title: 'Red clover extract does not demonstrate estrogenic activity: a randomized endometrial biopsy study',
      authors: ['Powles TJ', 'Howell A', 'Evans DG', 'McCloskey EV'],
      year: 2008,
      journal: 'British Journal of Cancer',
      language: 'English',
      qualityScore: 89,
      studyDesign: 'RCT',
      population: 'Postmenopausal women 50-70',
      sampleSize: 401,
      dose: '40 mg isoflavones/day (Promensil)',
      form: 'Promensil extract',
      duration: '3 years',
      endpoints: ['endometrial thickness', 'mammographic density', 'safety markers'],
      outcome: 'neutral',
      effectSummary: 'No estrogenic stimulation of endometrium. No change in mammographic density. Supports safety profile.',
    },
    {
      id: 'RC-007',
      title: 'Red clover for vasomotor symptoms: no significant benefit over placebo in a large multicenter trial',
      authors: ['Nelson HD', 'Vesco KK', 'Haney E'],
      year: 2006,
      journal: 'Annals of Internal Medicine',
      language: 'English',
      qualityScore: 91,
      studyDesign: 'RCT',
      population: 'Postmenopausal women with hot flashes',
      sampleSize: 318,
      dose: '40 mg isoflavones/day',
      form: 'Whole herb extract',
      duration: '12 weeks',
      endpoints: ['hot flash frequency', 'hot flash severity'],
      outcome: 'negative',
      effectSummary: 'No significant difference vs placebo (p=0.34). High placebo response rate (32%) noted.',
    },
    {
      id: 'RC-008',
      title: 'Dose-dependent effects of red clover isoflavones on menopausal hot flashes: an 8-week trial',
      authors: ['van de Weijer PHM', 'Barentsen R'],
      year: 2002,
      journal: 'Maturitas',
      language: 'English',
      qualityScore: 78,
      studyDesign: 'RCT',
      population: 'Postmenopausal women with ≥5 hot flashes/day',
      sampleSize: 60,
      dose: '40 mg vs 80 mg vs 160 mg isoflavones/day',
      form: 'Promensil extract',
      duration: '8 weeks',
      endpoints: ['hot flash frequency', 'hot flash severity'],
      outcome: 'supporting',
      effectSummary: '80 mg dose optimal (56% reduction). 160 mg no additional benefit. 40 mg modest effect.',
    },
    {
      id: 'RC-009',
      title: 'MF11RCE red clover isoflavone extract and cardiovascular risk markers in menopausal women',
      authors: ['Blakesmith SJ', 'Lyons-Wall PM', 'George C', 'Joannou GE'],
      year: 2017,
      journal: 'Phytomedicine',
      language: 'English',
      qualityScore: 80,
      studyDesign: 'RCT',
      population: 'Postmenopausal women 50-65',
      sampleSize: 74,
      dose: '80 mg isoflavones (MF11RCE)',
      form: 'MF11RCE',
      duration: '12 weeks',
      endpoints: ['arterial compliance', 'lipid profile', 'CRP'],
      outcome: 'supporting',
      effectSummary: 'Arterial compliance improved 23% (p=0.02). CRP reduced. Favorable lipid changes.',
    },
    {
      id: 'RC-010',
      title: 'A whole herb red clover preparation and hot flashes in perimenopausal women: a randomized pilot study',
      authors: ['Burdette JE', 'Liu J', 'Chen SN', 'Bolton JL'],
      year: 2019,
      journal: 'Journal of Womens Health',
      language: 'English',
      qualityScore: 69,
      studyDesign: 'RCT',
      population: 'Perimenopausal women 42-52',
      sampleSize: 44,
      dose: '500 mg dried whole herb extract',
      form: 'Whole herb',
      duration: '8 weeks',
      endpoints: ['hot flash frequency', 'menopause-specific quality of life'],
      outcome: 'neutral',
      effectSummary: 'Trend toward improvement (p=0.08). Small sample. Perimenopause subgroup showed more variability.',
    },
    {
      id: 'RC-011',
      title: 'Safety and tolerability of fermented red clover extract in postmenopausal women: a 2-year open-label extension study',
      authors: ['Mueller M', 'Hobiger S', 'Jungbauer A'],
      year: 2020,
      journal: 'Phytotherapy Research',
      language: 'English',
      qualityScore: 72,
      studyDesign: 'cohort',
      population: 'Postmenopausal women from prior RCT',
      sampleSize: 68,
      dose: '80 mg isoflavones/day',
      form: 'MF11RCE',
      duration: '2 years',
      endpoints: ['safety markers', 'endometrial thickness', 'liver function', 'hot flash frequency'],
      outcome: 'supporting',
      effectSummary: 'No serious adverse events. Endometrial thickness stable. Persistent hot flash reduction maintained.',
    },
    {
      id: 'RC-012',
      title: 'Red clover isoflavones and equol production: impact on menopausal symptom relief',
      authors: ['Setchell KD', 'Brown NM', 'Lydeking-Olsen E'],
      year: 2005,
      journal: 'Journal of Nutrition',
      language: 'English',
      qualityScore: 83,
      studyDesign: 'cohort',
      population: 'Postmenopausal women, equol producers vs non-producers',
      sampleSize: 134,
      dose: '80 mg isoflavones/day (Promensil)',
      form: 'Promensil extract',
      duration: '12 weeks',
      endpoints: ['hot flash frequency', 'equol status', 'urinary isoflavone metabolites'],
      outcome: 'supporting',
      effectSummary: 'Equol producers showed 61% reduction in hot flashes vs 32% in non-producers (p=0.003).',
    },
    {
      id: 'RC-013',
      title: 'Isoflavone-rich red clover extract and body composition in postmenopausal women: secondary analysis',
      authors: ['Chedraui P', 'San Miguel G', 'Hidalgo L', 'Morocho N'],
      year: 2016,
      journal: 'Gynecological Endocrinology',
      language: 'English',
      qualityScore: 71,
      studyDesign: 'RCT',
      population: 'Postmenopausal women BMI 25-35',
      sampleSize: 62,
      dose: '80 mg isoflavones (MF11RCE)',
      form: 'MF11RCE',
      duration: '12 weeks',
      endpoints: ['body composition', 'Kupperman index', 'fasting glucose'],
      outcome: 'neutral',
      effectSummary: 'No significant changes in body composition. Kupperman index improved (secondary endpoint).',
    },
    {
      id: 'RC-014',
      title: 'Promensil red clover extract and breast tissue density: a randomized placebo-controlled trial',
      authors: ['Powles TJ', 'Howell A', 'Evans DG'],
      year: 2010,
      journal: 'Breast Cancer Research and Treatment',
      language: 'English',
      qualityScore: 90,
      studyDesign: 'RCT',
      population: 'Postmenopausal women at average breast cancer risk',
      sampleSize: 205,
      dose: '40 mg isoflavones/day',
      form: 'Promensil extract',
      duration: '12 months',
      endpoints: ['mammographic density', 'breast tissue proliferation markers'],
      outcome: 'neutral',
      effectSummary: 'No change in mammographic density (p=0.89). No increase in Ki-67 staining. Reassuring safety signal.',
    },
    {
      id: 'RC-015',
      title: 'Combining red clover isoflavones with probiotics for enhanced menopausal symptom relief: a proof-of-concept RCT',
      authors: ['Lambert MNT', 'Thorup AC', 'Hansen ESS', 'Jeppesen PB'],
      year: 2017,
      journal: 'PLoS ONE',
      language: 'English',
      qualityScore: 77,
      studyDesign: 'RCT',
      population: 'Postmenopausal women 50-65',
      sampleSize: 60,
      dose: '80 mg isoflavones + L. acidophilus',
      form: 'Promensil + probiotic',
      duration: '12 weeks',
      endpoints: ['hot flash frequency', 'equol conversion', 'Kupperman index'],
      outcome: 'supporting',
      effectSummary: 'Combination arm: 71% hot flash reduction vs 48% isoflavone alone (p=0.02). Equol conversion enhanced.',
    },
    {
      id: 'RC-016',
      title: 'A multicenter randomized trial of red clover isoflavones for vasomotor symptoms: 6-month outcomes',
      authors: ['Geller SE', 'Shulman LP', 'van Breemen RB'],
      year: 2009,
      journal: 'Menopause',
      language: 'English',
      qualityScore: 85,
      studyDesign: 'RCT',
      population: 'Postmenopausal women with moderate-to-severe hot flashes',
      sampleSize: 184,
      dose: '120 mg isoflavones/day',
      form: 'Promensil extract',
      duration: '24 weeks',
      endpoints: ['hot flash frequency', 'hot flash severity composite', 'Greene Climacteric Scale'],
      outcome: 'supporting',
      effectSummary: 'Hot flash frequency reduced 52% at 24 weeks (p<0.001). Effect sustained over 6-month period.',
    },
  ],

  // ---- Ingredient forms --------------------------------------------------
  ingredientForms: [
    {
      form: 'Promensil standardized extract',
      isoflavoneContent: '40-80 mg total isoflavones (biochanin A, formononetin, genistein, daidzein)',
      standardization: 'Standardized to total isoflavone content',
      efficacySummary: 'Most extensively studied form. Strong evidence for hot flash reduction. 80 mg dose appears optimal. Well-characterized phytochemical profile.',
      studyCount: 9,
    },
    {
      form: 'MF11RCE standardized extract',
      isoflavoneContent: '80 mg total isoflavones (fermented)',
      standardization: 'Fermentation-enhanced bioavailability',
      efficacySummary: 'Fermented extract may increase equol conversion rates. Good evidence for Kupperman index improvement. Potentially beneficial for equol non-producers.',
      studyCount: 5,
    },
    {
      form: 'Whole herb (dried extract)',
      isoflavoneContent: 'Variable (15-40 mg isoflavones depending on preparation)',
      standardization: 'Unstandardized',
      efficacySummary: 'Limited and inconsistent evidence. Variable isoflavone content makes dosing unreliable. Not recommended for claim substantiation.',
      studyCount: 2,
    },
  ],

  // ---- Endpoint analysis -------------------------------------------------
  endpointAnalysis: [
    {
      endpoint: 'Hot Flash Frequency',
      totalStudies: 12,
      supporting: 8,
      neutral: 3,
      negative: 1,
      averageEffectSize: 'WMD -1.31 flashes/day',
    },
    {
      endpoint: 'Hot Flash Severity',
      totalStudies: 8,
      supporting: 6,
      neutral: 2,
      negative: 0,
      averageEffectSize: 'SMD -0.54 (moderate)',
    },
    {
      endpoint: 'Kupperman Index',
      totalStudies: 6,
      supporting: 5,
      neutral: 1,
      negative: 0,
      averageEffectSize: 'WMD -8.7 points',
    },
    {
      endpoint: 'Bone Density Markers',
      totalStudies: 4,
      supporting: 2,
      neutral: 2,
      negative: 0,
      averageEffectSize: 'Attenuated BMD loss ~1.2%/year',
    },
    {
      endpoint: 'Lipid Profile (HDL-C)',
      totalStudies: 5,
      supporting: 3,
      neutral: 2,
      negative: 0,
      averageEffectSize: 'WMD +4.8 mg/dL HDL-C',
    },
  ],

  // ---- Dosage ranges -----------------------------------------------------
  dosageRanges: [
    { form: 'Promensil extract', effectiveDose: '40-80 mg total isoflavones/day', optimalDose: '80 mg/day', timing: 'Once daily with food' },
    { form: 'MF11RCE', effectiveDose: '80 mg total isoflavones/day', optimalDose: '80 mg/day', timing: 'Once daily with food' },
    { form: 'Whole herb extract', effectiveDose: 'Not well established', optimalDose: 'N/A', timing: 'Variable' },
  ],

  // ---- Research gaps -----------------------------------------------------
  researchGaps: [
    { gap: 'Limited long-term safety data (>3 years)', severity: 'High', detail: 'Only one extension study at 2 years. No RCTs beyond 3 years for cancer safety outcomes.' },
    { gap: 'Few studies in early perimenopause', severity: 'High', detail: 'Most data in postmenopausal women. Only 1 pilot study in perimenopausal women. Earlier intervention may yield different results.' },
    { gap: 'Equol producer status as effect modifier', severity: 'Moderate', detail: 'Equol production status significantly impacts efficacy. No RCTs stratifying by equol phenotype at enrollment.' },
    { gap: 'Interaction with hormonal therapies', severity: 'Moderate', detail: 'No studies evaluating co-administration with low-dose HRT or bioidentical hormones.' },
    { gap: 'Ethnic variation in response', severity: 'Moderate', detail: 'Most data in Caucasian populations. Limited data in Asian and African-descent women.' },
    { gap: 'Sleep-specific menopausal outcomes', severity: 'Low', detail: 'Hot flash reduction may improve sleep, but dedicated sleep outcome measures lacking in most trials.' },
  ],

  // ---- Suggested claims --------------------------------------------------
  suggestedClaims: [
    {
      claimText: 'Red clover isoflavone extract (80 mg/day) supports reduction in the frequency and intensity of menopausal hot flashes in postmenopausal women.',
      confidence: 'Strong',
      evidenceLevel: '1a (meta-analysis of RCTs)',
      regulatoryContext: 'Structure/function claim. Substantiable under DSHEA. Consistent with TGA listed medicine claim. EFSA Art. 13.5 application feasible.',
      supportingStudyCount: 10,
    },
    {
      claimText: 'Red clover isoflavones may help maintain a favorable lipid profile and support cardiovascular wellness during menopause.',
      confidence: 'Moderate',
      evidenceLevel: '2a (consistent RCT findings, limited to secondary endpoints)',
      regulatoryContext: 'Structure/function claim with qualifier. HDL and arterial compliance data supportive but not primary endpoint in most studies.',
      supportingStudyCount: 5,
    },
    {
      claimText: 'Standardized red clover extract shows emerging evidence for supporting bone mineral density maintenance in postmenopausal women.',
      confidence: 'Emerging',
      evidenceLevel: '2b (limited RCTs, mixed significance)',
      regulatoryContext: 'Requires qualifying language. Insufficient for standalone bone health claim. Could be part of a broader menopausal wellness claim.',
      supportingStudyCount: 3,
    },
  ],

  // ---- Consumer / social data -------------------------------------------
  consumerSocial: {
    sentimentScore: 0.68,
    sampleSize: 8470,
    dataWindow: '2024-01-01 to 2025-10-31',
    commonQuestions: [
      'Is red clover safe for long-term use?',
      'Does red clover increase estrogen levels?',
      'How long does red clover take to work for hot flashes?',
      'Can I take red clover with HRT?',
      'Is red clover safe if I had breast cancer?',
    ],
    brandMentions: [
      { brand: 'Pure Encapsulations', mentions: 890, sentiment: 0.76, topAssociation: 'practitioner-grade isoflavones' },
      { brand: 'Solgar', mentions: 1420, sentiment: 0.71, topAssociation: 'red clover capsules affordability' },
      { brand: "Nature's Bounty", mentions: 960, sentiment: 0.62, topAssociation: 'menopause supplement bundles' },
      { brand: 'Vital Proteins', mentions: 110, sentiment: 0.58, topAssociation: 'not a primary association' },
    ],
    topChannels: [
      { channel: 'Reddit (r/Menopause, r/Supplements)', posts: 2180 },
      { channel: 'Facebook Groups (Menopause)', posts: 2650 },
      { channel: 'Amazon Reviews', posts: 1940 },
      { channel: 'Health Forums (Menopause Matters)', posts: 1020 },
      { channel: 'Instagram', posts: 680 },
    ],
  },
};

// ===========================================================================
// 3. COLLAGEN + SKIN ELASTICITY
// ===========================================================================
const collagenSkin = {
  ingredientId: 'collagen_skin',
  ingredient: 'Collagen Peptides',
  claimArea: 'Skin Elasticity Improvement',

  // ---- Ingestion stats ---------------------------------------------------
  ingestion: {
    totalPapersIdentified: 384,
    fullTextAccessed: 312,
    duplicatesRemoved: 29,
    excludedAfterScreening: 43,
    dataSources: [
      { name: 'PubMed / MEDLINE', papers: 158 },
      { name: 'ClinicalTrials.gov', papers: 42 },
      { name: 'Cochrane Library', papers: 14 },
      { name: 'Internal Nestlé R&D Archive', papers: 41 },
      { name: 'J-STAGE', papers: 22 },
      { name: 'EMBASE', papers: 19 },
      { name: 'Consumer / Social Media', papers: 88 },
    ],
    languagesDetected: ['English', 'Japanese', 'Korean', 'German', 'French', 'Chinese'],
    dateRange: { from: '2007-01-01', to: '2025-12-01' },
    avgProcessingTimeSec: 0.45,
  },

  // ---- Studies -----------------------------------------------------------
  studies: [
    {
      id: 'CL-001',
      title: 'Oral supplementation with specific bioactive collagen peptides improves skin elasticity: a randomized, double-blind, placebo-controlled study',
      authors: ['Proksch E', 'Segger D', 'Degwert J', 'Hartmann M'],
      year: 2014,
      journal: 'Skin Pharmacology and Physiology',
      language: 'English',
      qualityScore: 89,
      studyDesign: 'RCT',
      population: 'Women 35-55',
      sampleSize: 69,
      dose: '2.5 g or 5 g collagen peptides/day',
      form: 'Type I hydrolyzed collagen peptides',
      duration: '8 weeks',
      endpoints: ['skin elasticity (cutometry)', 'skin hydration'],
      outcome: 'supporting',
      effectSummary: 'Skin elasticity improved 7% (2.5 g) and 9% (5 g) vs placebo. Significant at both doses (p<0.05).',
    },
    {
      id: 'CL-002',
      title: 'Oral collagen peptide supplementation significantly improves skin hydration, elasticity, roughness, and density: a systematic review and meta-analysis',
      authors: ['de Miranda RB', 'Weimer P', 'Rossi RC'],
      year: 2021,
      journal: 'International Journal of Dermatology',
      language: 'English',
      qualityScore: 92,
      studyDesign: 'meta-analysis',
      population: 'Adults, majority female',
      sampleSize: 1721,
      dose: '2.5-10 g/day',
      form: 'Multiple collagen types',
      duration: '4-24 weeks',
      endpoints: ['skin elasticity', 'skin hydration', 'wrinkle depth', 'skin density'],
      outcome: 'supporting',
      effectSummary: 'Significant improvements in elasticity (SMD 0.71, p<0.001) and hydration (SMD 0.62, p<0.001).',
    },
    {
      id: 'CL-003',
      title: 'Effect of oral intake of low-molecular-weight collagen peptides derived from fish on skin elasticity and wrinkle depth in middle-aged Japanese women',
      authors: ['Inoue N', 'Sugihara F', 'Wang X'],
      year: 2016,
      journal: 'Journal of the Science of Food and Agriculture',
      language: 'English',
      qualityScore: 84,
      studyDesign: 'RCT',
      population: 'Japanese women 40-59',
      sampleSize: 85,
      dose: '5 g fish collagen peptides/day',
      form: 'Fish collagen peptides',
      duration: '8 weeks',
      endpoints: ['skin elasticity (cutometry)', 'wrinkle depth', 'transepidermal water loss'],
      outcome: 'supporting',
      effectSummary: 'Elasticity R2 increased 12.1% vs baseline (p=0.007). Wrinkle volume reduced 8.1% (p=0.02).',
    },
    {
      id: 'CL-004',
      title: 'Daily consumption of a marine collagen peptide-enriched drink improves skin elasticity, hydration, and TEWL: a double-blind, placebo-controlled study',
      authors: ['Asserin J', 'Lati E', 'Shioya T', 'Prawitt J'],
      year: 2015,
      journal: 'Journal of Cosmetic Dermatology',
      language: 'English',
      qualityScore: 86,
      studyDesign: 'RCT',
      population: 'Women 40-65',
      sampleSize: 106,
      dose: '10 g marine collagen peptides/day',
      form: 'Fish collagen peptides',
      duration: '8 weeks',
      endpoints: ['skin hydration', 'collagen density (ultrasound)', 'TEWL', 'skin firmness'],
      outcome: 'supporting',
      effectSummary: 'Skin collagen density increased 9% (p<0.01). TEWL reduced. Hydration increased in subgroup analysis.',
    },
    {
      id: 'CL-005',
      title: 'Ingestion of bioactive collagen peptides reduces skin wrinkles: a randomized, double-blind, placebo-controlled clinical trial with objective photographic assessment',
      authors: ['Proksch E', 'Schunck M', 'Zague V', 'Segger D'],
      year: 2014,
      journal: 'Skin Pharmacology and Physiology',
      language: 'English',
      qualityScore: 87,
      studyDesign: 'RCT',
      population: 'Women 45-65 with moderate wrinkles',
      sampleSize: 114,
      dose: '2.5 g specific bioactive collagen peptides/day',
      form: 'Type I hydrolyzed collagen peptides',
      duration: '8 weeks + 4 week washout',
      endpoints: ['eye wrinkle volume', 'procollagen I', 'elastin', 'fibrillin'],
      outcome: 'supporting',
      effectSummary: 'Eye wrinkle volume reduced 20% (p<0.001). Procollagen I increased 65% at 8 weeks. Effect partially persisted post-washout.',
    },
    {
      id: 'CL-006',
      title: 'Bovine collagen peptides and skin aging markers: a 12-week randomized controlled trial in postmenopausal women',
      authors: ['Bolke L', 'Schlippe G', 'Gerss J', 'Voss W'],
      year: 2019,
      journal: 'Nutrients',
      language: 'English',
      qualityScore: 85,
      studyDesign: 'RCT',
      population: 'Postmenopausal women 50-70',
      sampleSize: 72,
      dose: '5 g bovine collagen peptides/day',
      form: 'Bovine collagen',
      duration: '12 weeks',
      endpoints: ['skin elasticity', 'skin hydration', 'wrinkle depth', 'dermis density'],
      outcome: 'supporting',
      effectSummary: 'Elasticity improved 16.3% (p<0.001). Wrinkle depth reduced 17.3%. Dermis thickness increased 7.5%.',
    },
    {
      id: 'CL-007',
      title: 'Type I and III collagen blend supplementation and skin biomechanical properties: a randomized trial',
      authors: ['Kim DU', 'Chung HC', 'Choi J', 'Sakai Y'],
      year: 2018,
      journal: 'Journal of Medicinal Food',
      language: 'English',
      qualityScore: 81,
      studyDesign: 'RCT',
      population: 'Women 30-60',
      sampleSize: 64,
      dose: '1 g Type I + III collagen peptides/day',
      form: 'Type I+III blend',
      duration: '12 weeks',
      endpoints: ['skin elasticity', 'moisture content', 'TEWL'],
      outcome: 'supporting',
      effectSummary: 'Skin elasticity by cutometry improved 11% (p=0.013). Moisture improved 19% (p=0.003). TEWL reduced.',
    },
    {
      id: 'CL-008',
      title: 'Collagen peptide supplementation in combination with resistance training does not improve skin elasticity beyond collagen alone',
      authors: ['Zdzieblik D', 'Oesser S', 'Baumstark MW', 'Gollhofer A'],
      year: 2020,
      journal: 'Journal of the International Society of Sports Nutrition',
      language: 'English',
      qualityScore: 78,
      studyDesign: 'RCT',
      population: 'Active women 25-50',
      sampleSize: 80,
      dose: '15 g collagen peptides/day + exercise vs collagen alone',
      form: 'Type I hydrolyzed collagen peptides',
      duration: '12 weeks',
      endpoints: ['skin elasticity', 'body composition', 'skin hydration'],
      outcome: 'neutral',
      effectSummary: 'Both groups improved elasticity similarly (~8%). Exercise did not confer additional skin benefit. Confirms collagen-specific effect.',
    },
    {
      id: 'CL-009',
      title: 'Short-term supplementation with low-dose collagen peptides shows no significant effect on skin parameters: a 4-week study',
      authors: ['Schwartz SR', 'Park J'],
      year: 2012,
      journal: 'Clinical Interventions in Aging',
      language: 'English',
      qualityScore: 68,
      studyDesign: 'RCT',
      population: 'Women 35-55',
      sampleSize: 43,
      dose: '1 g collagen peptides/day',
      form: 'Type I hydrolyzed collagen peptides',
      duration: '4 weeks',
      endpoints: ['skin elasticity', 'skin hydration'],
      outcome: 'negative',
      effectSummary: 'No significant changes in elasticity or hydration. Duration and dose may have been insufficient.',
    },
    {
      id: 'CL-010',
      title: '魚由来コラーゲンペプチドの経口摂取による皮膚弾力性改善効果',
      authors: ['Matsumoto H', 'Ohara H', 'Ito K', 'Nakamura Y'],
      year: 2006,
      journal: 'J-STAGE: 日本食品科学工学会誌',
      language: 'Japanese',
      qualityScore: 77,
      studyDesign: 'RCT',
      population: 'Japanese women 30-50',
      sampleSize: 33,
      dose: '10 g fish collagen peptides/day',
      form: 'Fish collagen peptides',
      duration: '6 weeks',
      endpoints: ['skin elasticity', 'skin moisture'],
      outcome: 'supporting',
      effectSummary: 'Significant elasticity increase on cheeks (+8.3%, p=0.02). Moisture increased in forearm skin.',
    },
    {
      id: 'CL-011',
      title: 'A comparative study of bovine and fish collagen peptides on skin hydration and elasticity',
      authors: ['Sibilla S', 'Godfrey M', 'Brewer S', 'Budh-Raja A'],
      year: 2015,
      journal: 'Journal of the Science of Food and Agriculture',
      language: 'English',
      qualityScore: 79,
      studyDesign: 'RCT',
      population: 'Women 35-65',
      sampleSize: 120,
      dose: '5 g/day (bovine arm vs fish arm)',
      form: 'Bovine collagen vs fish collagen peptides',
      duration: '12 weeks',
      endpoints: ['skin elasticity', 'skin hydration', 'wrinkle depth'],
      outcome: 'supporting',
      effectSummary: 'Both sources improved elasticity. Fish collagen showed faster onset (4 weeks vs 8 weeks). No significant difference at 12 weeks.',
    },
    {
      id: 'CL-012',
      title: 'The oral intake of specific bioactive collagen peptides has a positive effect on hair thickness and skin elasticity: a randomized, placebo-controlled study',
      authors: ['Oesser S', 'Schulze CH', 'Niehoff A'],
      year: 2020,
      journal: 'Journal of Nutrition and Food Sciences',
      language: 'English',
      qualityScore: 76,
      studyDesign: 'RCT',
      population: 'Women 39-59',
      sampleSize: 44,
      dose: '2.5 g bioactive collagen peptides/day',
      form: 'Type I hydrolyzed collagen peptides',
      duration: '16 weeks',
      endpoints: ['skin elasticity', 'hair thickness', 'nail brittleness'],
      outcome: 'supporting',
      effectSummary: 'Skin elasticity increased by 8% at week 16 (p=0.03). Hair thickness improved in subgroup.',
    },
    {
      id: 'CL-013',
      title: 'Oral collagen peptides for skin aging in women: a 24-week dose-response study',
      authors: ['Choi FD', 'Sung CT', 'Juhasz MLW', 'Mesinkovsk NA'],
      year: 2019,
      journal: 'Dermatology and Therapy',
      language: 'English',
      qualityScore: 83,
      studyDesign: 'RCT',
      population: 'Women 40-60 with moderate photoaging',
      sampleSize: 150,
      dose: '2.5 g vs 5 g vs 10 g/day',
      form: 'Type I hydrolyzed collagen peptides',
      duration: '24 weeks',
      endpoints: ['skin elasticity', 'wrinkle depth', 'skin hydration', 'global assessment'],
      outcome: 'supporting',
      effectSummary: 'Dose-response observed: 10 g showed 14.2% elasticity gain vs 7.8% for 2.5 g. Plateau suggested between 5-10 g.',
    },
    {
      id: 'CL-014',
      title: 'Collagen peptides do not improve skin elasticity in men: a randomized controlled trial',
      authors: ['Evans M', 'Lewis ED', 'Zakaria N', 'Pelipyagina T'],
      year: 2021,
      journal: 'Journal of Cosmetic Dermatology',
      language: 'English',
      qualityScore: 80,
      studyDesign: 'RCT',
      population: 'Men 35-65',
      sampleSize: 60,
      dose: '5 g collagen peptides/day',
      form: 'Type I hydrolyzed collagen peptides',
      duration: '12 weeks',
      endpoints: ['skin elasticity', 'skin hydration', 'wrinkle volume'],
      outcome: 'neutral',
      effectSummary: 'Non-significant improvement in elasticity (p=0.12). Hydration modestly improved. May require higher dose or longer duration in men.',
    },
    {
      id: 'CL-015',
      title: 'A randomized controlled trial of collagen drink on skin properties and dermal collagen synthesis in UV-damaged skin',
      authors: ['Sangsuwan P', 'Suttiprapaporn P'],
      year: 2020,
      journal: 'Journal of Functional Foods',
      language: 'English',
      qualityScore: 82,
      studyDesign: 'RCT',
      population: 'Women 30-50 with UV-damaged forearm skin',
      sampleSize: 88,
      dose: '5 g marine collagen + vitamin C',
      form: 'Fish collagen peptides',
      duration: '12 weeks',
      endpoints: ['skin elasticity', 'UV-induced wrinkles', 'procollagen type I'],
      outcome: 'supporting',
      effectSummary: 'Skin elasticity recovered 11.5% toward pre-damage baseline (p=0.003). Procollagen I synthesis increased.',
    },
    {
      id: 'CL-016',
      title: 'Systematic review of oral collagen supplementation on skin aging: methodological quality assessment',
      authors: ['Baumann L', 'Bernstein EF', 'Beasley KL'],
      year: 2023,
      journal: 'Journal of Drugs in Dermatology',
      language: 'English',
      qualityScore: 88,
      studyDesign: 'systematic-review',
      population: 'Adults, predominantly female',
      sampleSize: 2840,
      dose: '1-15 g/day',
      form: 'All collagen sources',
      duration: '4-24 weeks',
      endpoints: ['skin elasticity', 'hydration', 'wrinkle depth', 'TEWL'],
      outcome: 'supporting',
      effectSummary: 'Consistent evidence for elasticity improvement (12/15 RCTs positive). Duration >= 8 weeks and dose >= 2.5 g appear necessary.',
    },
    {
      id: 'CL-017',
      title: 'コラーゲンペプチド長期摂取による皮膚粘弾性への影響：24週間二重盲検試験',
      authors: ['Ohara H', 'Matsumoto H', 'Ito K', 'Iwai K'],
      year: 2010,
      journal: 'J-STAGE: Bioscience, Biotechnology, and Biochemistry',
      language: 'Japanese',
      qualityScore: 80,
      studyDesign: 'RCT',
      population: 'Japanese women 35-55',
      sampleSize: 56,
      dose: '5 g porcine collagen peptides/day',
      form: 'Type I hydrolyzed collagen peptides',
      duration: '24 weeks',
      endpoints: ['skin viscoelasticity', 'skin hydration', 'subjective skin assessment'],
      outcome: 'supporting',
      effectSummary: 'Progressive improvement in skin viscoelasticity through 24 weeks. Maximum effect at 16-20 weeks.',
    },
  ],

  // ---- Ingredient forms --------------------------------------------------
  ingredientForms: [
    {
      form: 'Type I hydrolyzed collagen peptides (bovine/porcine)',
      molecularWeight: '2-6 kDa',
      source: 'Bovine hide or porcine skin',
      efficacySummary: 'Most extensively studied. Strong evidence for elasticity and wrinkle reduction at 2.5-10 g/day. Consistent results across multiple RCTs. 8+ weeks needed for measurable effect.',
      studyCount: 10,
    },
    {
      form: 'Type I + III collagen blend',
      molecularWeight: '3-8 kDa',
      source: 'Bovine',
      efficacySummary: 'Type III addition may support dermal matrix remodeling. Limited comparative data. One RCT shows efficacy at 1 g/day (low dose), suggesting enhanced bioactivity of blend.',
      studyCount: 3,
    },
    {
      form: 'Fish collagen peptides (marine)',
      molecularWeight: '1-5 kDa (typically lower MW)',
      source: 'Fish skin/scales (tilapia, cod, salmon)',
      efficacySummary: 'Lower molecular weight may improve absorption. Good evidence from Japanese studies. Faster onset of action suggested in one comparative study. Suitable for pescatarian market.',
      studyCount: 6,
    },
    {
      form: 'Bovine collagen peptides',
      molecularWeight: '3-6 kDa',
      source: 'Grass-fed bovine',
      efficacySummary: 'Widely available and cost-effective. Strong evidence at 5 g/day. Results comparable to other sources at equivalent doses and durations.',
      studyCount: 4,
    },
  ],

  // ---- Endpoint analysis -------------------------------------------------
  endpointAnalysis: [
    {
      endpoint: 'Skin Elasticity (Cutometry R2/R7)',
      totalStudies: 15,
      supporting: 12,
      neutral: 2,
      negative: 1,
      averageEffectSize: 'SMD 0.71 (moderate-large)',
    },
    {
      endpoint: 'Wrinkle Depth / Volume',
      totalStudies: 10,
      supporting: 8,
      neutral: 2,
      negative: 0,
      averageEffectSize: 'Mean reduction 13.2%',
    },
    {
      endpoint: 'Skin Hydration',
      totalStudies: 12,
      supporting: 9,
      neutral: 3,
      negative: 0,
      averageEffectSize: 'SMD 0.62 (moderate)',
    },
    {
      endpoint: 'TEWL (Transepidermal Water Loss)',
      totalStudies: 6,
      supporting: 4,
      neutral: 2,
      negative: 0,
      averageEffectSize: 'WMD -2.8 g/m2/h',
    },
  ],

  // ---- Dosage ranges -----------------------------------------------------
  dosageRanges: [
    { form: 'Type I hydrolyzed peptides', effectiveDose: '2.5-10 g/day', optimalDose: '5 g/day', timing: 'Once daily, any time. With vitamin C for enhanced synthesis.' },
    { form: 'Type I + III blend', effectiveDose: '1-5 g/day', optimalDose: '2.5-5 g/day', timing: 'Once daily' },
    { form: 'Fish collagen peptides', effectiveDose: '5-10 g/day', optimalDose: '5 g/day', timing: 'Once daily, dissolve in liquid' },
    { form: 'Bovine collagen peptides', effectiveDose: '5-15 g/day', optimalDose: '5 g/day', timing: 'Once daily, with or without food' },
  ],

  // ---- Research gaps -----------------------------------------------------
  researchGaps: [
    { gap: 'Limited data in diverse skin types (Fitzpatrick IV-VI)', severity: 'High', detail: 'Majority of RCTs in Caucasian and East Asian women. Only 2 studies include darker skin tones. Structural differences may affect outcomes.' },
    { gap: 'Dosing duration variability', severity: 'High', detail: 'Studies range from 4 to 24 weeks. Optimal treatment duration not established. No data on plateau or diminishing returns.' },
    { gap: 'Male-specific data limited', severity: 'Moderate', detail: 'Only 1 RCT exclusively in men (neutral outcome). Most mixed-gender studies underpowered for sex-stratified analysis.' },
    { gap: 'Source comparison studies limited', severity: 'Moderate', detail: 'Only 1 direct bovine vs fish comparison. No RCTs comparing marine vs porcine or hydrolyzed vs undenatured type II.' },
    { gap: 'Mechanism of absorption unclear', severity: 'Moderate', detail: 'Dipeptides (Pro-Hyp, Hyp-Gly) detected in blood, but direct dermal delivery mechanism debated. More pharmacokinetic studies needed.' },
    { gap: 'Environmental and lifestyle confounders', severity: 'Low', detail: 'Few studies control for UV exposure, smoking, topical skincare. These may obscure or amplify collagen peptide effects.' },
  ],

  // ---- Suggested claims --------------------------------------------------
  suggestedClaims: [
    {
      claimText: 'Daily supplementation with hydrolyzed collagen peptides (2.5-5 g/day) supports measurable improvement in skin elasticity, as demonstrated in multiple clinical studies using validated cutometry assessments.',
      confidence: 'Strong',
      evidenceLevel: '1a (meta-analysis of 15+ RCTs)',
      regulatoryContext: 'Structure/function claim. Well-substantiated under DSHEA. Consistent with EFSA novel food dossier requirements. Japan FOSHU precedent exists.',
      supportingStudyCount: 14,
    },
    {
      claimText: 'Collagen peptide supplementation supports skin hydration and may help reduce the appearance of fine lines and wrinkles with continued use of 8 weeks or more.',
      confidence: 'Strong',
      evidenceLevel: '1a (consistent RCT evidence)',
      regulatoryContext: 'Structure/function claim. Dual endpoint (hydration + wrinkles) well-supported. Time qualifier strengthens defensibility.',
      supportingStudyCount: 11,
    },
    {
      claimText: 'Fish-derived (marine) collagen peptides provide a bioavailable source of Type I collagen building blocks that support skin structural integrity.',
      confidence: 'Moderate',
      evidenceLevel: '2a (multiple RCTs, limited head-to-head)',
      regulatoryContext: 'Structure/function claim for marine-specific product positioning. Source-specific efficacy evidence growing but not as deep as general collagen evidence.',
      supportingStudyCount: 6,
    },
  ],

  // ---- Consumer / social data -------------------------------------------
  consumerSocial: {
    sentimentScore: 0.82,
    sampleSize: 23540,
    dataWindow: '2024-01-01 to 2025-10-31',
    commonQuestions: [
      'Does collagen really work for skin or is it hype?',
      'What is the best type of collagen for skin?',
      'How long does it take to see results from collagen?',
      'Is marine collagen better than bovine for skin?',
      'Can I take collagen if I have a fish allergy?',
    ],
    brandMentions: [
      { brand: 'Vital Proteins', mentions: 8420, sentiment: 0.84, topAssociation: 'collagen peptides market leader' },
      { brand: 'Pure Encapsulations', mentions: 1640, sentiment: 0.79, topAssociation: 'clean-label collagen quality' },
      { brand: 'Solgar', mentions: 1120, sentiment: 0.70, topAssociation: 'collagen tablets traditional format' },
      { brand: "Nature's Bounty", mentions: 2360, sentiment: 0.67, topAssociation: 'collagen gummies accessibility' },
    ],
    topChannels: [
      { channel: 'TikTok', posts: 7840 },
      { channel: 'Instagram', posts: 5620 },
      { channel: 'Amazon Reviews', posts: 4310 },
      { channel: 'Reddit (r/SkincareAddiction, r/Supplements)', posts: 3260 },
      { channel: 'YouTube', posts: 2510 },
    ],
  },
};

// ===========================================================================
// Exported data map
// ===========================================================================
export const INGREDIENT_DATA = {
  magnesium_sleep: magnesiumSleep,
  red_clover_menopause: redCloverMenopause,
  collagen_skin: collagenSkin,
};

// ===========================================================================
// Helper: retrieve demo context for a given ingredient ID
// ===========================================================================
export function getDemoContext(ingredientId) {
  if (!ingredientId) {
    return INGREDIENT_DATA.magnesium_sleep;
  }
  const data = INGREDIENT_DATA[ingredientId];
  if (!data) {
    throw new Error(
      `Unknown ingredient ID "${ingredientId}". Valid IDs: ${Object.keys(INGREDIENT_DATA).join(', ')}`
    );
  }
  return data;
}
